Koneksa Publishes Syndication Model to Accelerate Drug Discovery
10 Dec 2024 //
BUSINESSWIRE
Koneksa Appoints Eric Luthi as Chief Business Officer
11 Nov 2024 //
BUSINESSWIRE
Regeneron Joins Koneksa`s Program for Parkinson`s Digital Biomarkers Study
03 Sep 2024 //
BUSINESSWIRE
Koneksa to Collect Patient Data in Lung Cancer Proton Therapy Study
25 Apr 2024 //
BUSINESSWIRE
Koneksa Appoints Dr. Jessie Bakker as Vice President of Clinical Development
04 Mar 2024 //
BUSINESSWIRE
Koneksa Enrolls First Patient in LEARNS Observational Study
20 Feb 2024 //
BUSINESSWIRE
Koneksa Announces New Multi-Domain Model for Functional Status Assessment
04 Jan 2024 //
BUSINESSWIRE
Koneksa Appoints Dave Hurry as Chief Data Officer and Dr. Larsson Omberg as EVP
27 Jun 2023 //
BUSINESSWIRE
Koneksa Announces Partnership with Beacon Biosignals
13 Jun 2023 //
BUSINESSWIRE
Koneksa links with SSI to advance digital biomarker services
09 Mar 2023 //
FIERCE BIOTECH
Koneksa, SSI Strategy expand partnership for biomarker adoption in trials
03 Mar 2023 //
CLINICAL TRIALS ARENA
Koneksa Announces Expanded Partnership with SSI Strategy
02 Mar 2023 //
BUSINESSWIRE
Koneksa Launches Trial Evaluating At-Home Mobile Spirometry in Moderate Asthma
17 Jan 2023 //
BUSINESSWIRE
Koneksa Announces Clinical Pipeline of Validated Digital Biomarkers
25 Oct 2022 //
BUSINESSWIRE
Koneksa aims to answer Parkinson’s-tracking challenge with AI
09 Aug 2022 //
PHARMAPHORUM
Koneksa Appoints Dr. Maria C. Freire to Board of Directors
19 Jul 2022 //
BUSINESSWIRE
Aural and Koneksa Announce Partnership to Support Trials Using Speech Analytics
14 Jun 2022 //
BUSINESSWIRE
Koneksa Raises $45M Series C Financing for Digital Biomarker Platform
07 Feb 2022 //
BUSINESSWIRE